S&P और Nasdaq का आंतरिक मूल्य संपर्क करें

Eli Lilly and Company LLY NYSE

NYSE • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
86/100
5/7 Pass
SharesGrow Intrinsic Value
$919.68
-0.3%
Analyst Price Target
$1,243.95
+34.8%

Eli Lilly and Company (LLY) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Drug Manufacturers - General उद्योग. कंपनी का मुख्यालय है Indianapolis, IN, United States. वर्तमान CEO हैं David A. Ricks.

LLY के पास है IPO तिथि 1972-06-01, 47,000 पूर्णकालिक कर्मचारी, पर सूचीबद्ध NYSE, बाजार पूंजीकरण $871.6B.

Eli Lilly and Company के बारे में

Eli Lilly and Company is a global pharmaceutical company that discovers, develops, and markets a comprehensive portfolio of human pharmaceuticals across multiple therapeutic areas. The company's offerings span diabetes management with products like Humalog and Humulin insulins, oncology with agents including Alimta, Cyramza, and Verzenio for various cancers, immunology with Olumiant and Taltz for rheumatoid arthritis and psoriatic conditions, and neuroscience with medications such as Cymbalta and Zyprexa. Additionally, Eli Lilly provides treatments for other indications including erectile dysfunction, osteoporosis, and COVID-19, supported by strategic collaborations with leading biotechnology firms. Founded in 1876 and headquartered in Indianapolis, Indiana, the company maintains a strong commitment to innovation and therapeutic advancement across its diverse drug pipeline.

📍 Lilly Corporate Center, Indianapolis, IN 46285 📞 317 276 2000
कंपनी विवरण
क्षेत्रस्वास्थ्य सेवा
उद्योगDrug Manufacturers - General
देशUnited States
एक्सचेंजNYSE
मुद्राUSD
IPO तिथि1972-06-01
सीईओDavid A. Ricks
कर्मचारी47,000
ट्रेडिंग जानकारी
वर्तमान मूल्य$922.50
बाज़ार पूंजीकरण$871.6B
52-सप्ताह रेंज623.78-1133.95
Beta0.50
ETFनहीं
ADRनहीं
CUSIP532457108
संपर्क करें
🎓
SharesGrow अकादमी
आंतरिक मूल्य गणना और कम मूल्य स्टॉक खोजना सीखें।
साप्ताहिक लाइव सत्र
हमें संदेश भेजें